Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
179.12
+5.82 (3.36%)
At close: Mar 9, 2026, 4:00 PM EDT
182.00
+2.88 (1.61%)
After-hours: Mar 9, 2026, 7:48 PM EDT
Belite Bio Stock Forecast
Stock Price Forecast
The 7 analysts that cover Belite Bio stock have a consensus rating of "Strong Buy" and an average price target of $181.14, which forecasts a 1.13% increase in the stock price over the next year. The lowest target is $80 and the highest is $266.
Price Target: $181.14 (+1.13%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Belite Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 4 | 4 | 4 |
| Buy | 1 | 2 | 3 | 4 | 4 | 4 |
| Hold | 0 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $185 → $200 | Strong Buy | Maintains | $185 → $200 | +11.66% | Mar 3, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $191 → $201 | Buy | Maintains | $191 → $201 | +12.22% | Mar 3, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $200 → $266 | Buy | Maintains | $200 → $266 | +48.50% | Mar 3, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $185 | Strong Buy | Reiterates | $185 | +3.28% | Jan 28, 2026 |
| B of A Securities | B of A Securities | Strong Buy Initiates $195 | Strong Buy | Initiates | $195 | +8.87% | Jan 26, 2026 |
Financial Forecast
Revenue This Year
43.71M
Revenue Next Year
139.19M
from 43.71M
Increased by 218.41%
EPS This Year
-1.26
from -2.31
EPS Next Year
-1.94
from -1.26
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 262.5M | 174.2M | |||
| Avg | 43.7M | 139.2M | |||
| Low | n/a | 57.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 298.4% | |||
| Avg | - | 218.4% | |||
| Low | - | 32.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.33 | -0.11 | |||
| Avg | -1.26 | -1.94 | |||
| Low | -2.98 | -3.64 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.